June 23, 2026

Clinical Oncology Education

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma a-new-frontier-in-hematology-teclistamab-redefines-treatment-for-high-risk-smoldering-multiple-myeloma

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

Nila Kartika Wati June 22, 2026
In a landmark development for the field of hematology, researchers from the Dana-Farber Cancer Institute have unveiled...
Read More Read more about A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma
Breakthrough in Breast Cancer Treatment: ASCENT-04 Trial Data Suggests New Standard of Care for Metastatic Triple-Negative Breast Cancer breakthrough-in-breast-cancer-treatment-ascent-04-trial-data-suggests-new-standard-of-care-for-metastatic-triple-negative-breast-cancer

Breakthrough in Breast Cancer Treatment: ASCENT-04 Trial Data Suggests New Standard of Care for Metastatic Triple-Negative Breast Cancer

Asro June 22, 2026
As the medical community prepares to convene in Chicago for the 2026 American Society of Clinical Oncology...
Read More Read more about Breakthrough in Breast Cancer Treatment: ASCENT-04 Trial Data Suggests New Standard of Care for Metastatic Triple-Negative Breast Cancer
Landmark Study: Personalized mRNA Cancer Vaccine Sustains 49% Reduction in Melanoma Recurrence After Five Years landmark-study-personalized-mrna-cancer-vaccine-sustains-49-reduction-in-melanoma-recurrence-after-five-years

Landmark Study: Personalized mRNA Cancer Vaccine Sustains 49% Reduction in Melanoma Recurrence After Five Years

Suro Senen June 22, 2026
In a significant breakthrough for oncology, a long-term study has revealed that a personalized mRNA vaccine, when...
Read More Read more about Landmark Study: Personalized mRNA Cancer Vaccine Sustains 49% Reduction in Melanoma Recurrence After Five Years
Unmasking the ‘Hidden’ Network: How Lymph Node Structural Changes Could Revolutionize Breast Cancer Care unmasking-the-hidden-network-how-lymph-node-structural-changes-could-revolutionize-breast-cancer-care

Unmasking the ‘Hidden’ Network: How Lymph Node Structural Changes Could Revolutionize Breast Cancer Care

Iffa Jayyana June 21, 2026
In a breakthrough that could fundamentally alter the landscape of breast cancer diagnostics and surgical intervention, a...
Read More Read more about Unmasking the ‘Hidden’ Network: How Lymph Node Structural Changes Could Revolutionize Breast Cancer Care
Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial redefining-treatment-for-high-risk-biochemically-recurrent-prostate-cancer-insights-from-the-embark-trial

Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

Rifan Muazin June 18, 2026
The landscape of prostate cancer treatment has undergone a significant transformation in recent years, particularly regarding the...
Read More Read more about Redefining Treatment for High-Risk Biochemically Recurrent Prostate Cancer: Insights from the EMBARK Trial

You may have missed

the-critical-two-weeks-mastering-the-specialty-pharmacy-patient-journey

The Critical Two Weeks: Mastering the Specialty Pharmacy Patient Journey

Laily UPN June 23, 2026
the-geometry-of-stillness-revisiting-the-timeless-wisdom-of-utthita-trikonasana

The Geometry of Stillness: Revisiting the Timeless Wisdom of Utthita Trikonasana

Sagoh June 23, 2026
rapid-diagnostics-revolution-genecaptures-breakthrough-promises-to-end-the-era-of-wait-and-see-medicine

Rapid Diagnostics Revolution: GeneCapture’s Breakthrough Promises to End the Era of "Wait-and-See" Medicine

Lina Irawan June 23, 2026
breakthrough-in-prostate-cancer-treatment-dual-drug-therapy-offers-new-hope-for-men-with-genetic-mutations

Breakthrough in Prostate Cancer Treatment: Dual-Drug Therapy Offers New Hope for Men with Genetic Mutations

Iffa Jayyana June 23, 2026